These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 17634078

  • 1. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K, Yamane K, Kamei N, Nojima H, Kohno N.
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [Abstract] [Full Text] [Related]

  • 2. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A, Tirado R, Vendrell J, Gallart L, Megía A, Simón I, Llauradó G, González-Clemente JM, Giménez-Palop O.
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
    Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V.
    Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
    [Abstract] [Full Text] [Related]

  • 4. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA, Barakat YA.
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [Abstract] [Full Text] [Related]

  • 5. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH, Lee JK, Wang MC, Lu CC, Sun CC, Chuang MJ, Lam HC.
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [Abstract] [Full Text] [Related]

  • 6. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [Abstract] [Full Text] [Related]

  • 7. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M, Lasa A, Simon E, Ares R, Larrarte E, Labayen I.
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [Abstract] [Full Text] [Related]

  • 8. [Association of serum interleukin-6 and high-sensitivity C-reactive protein levels with insulin resistance in gestational diabetes mellitus].
    Yu F, Xue YM, Li CZ, Shen J, Gao F, Yu YH, Fu XJ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):799-801. PubMed ID: 17584642
    [Abstract] [Full Text] [Related]

  • 9. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH.
    Clin Chim Acta; 2007 May 01; 380(1-2):68-74. PubMed ID: 17335789
    [Abstract] [Full Text] [Related]

  • 10. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ, Ma Xn, Hu XF, Kang SX, Chen SK, Cianflone K, Lu HL.
    J Pediatr Endocrinol Metab; 2013 May 01; 26(1-2):111-8. PubMed ID: 23327785
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of the adipokine visfatin are increased in pre-eclampsia.
    Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H.
    Clin Endocrinol (Oxf); 2008 Jul 01; 69(1):69-73. PubMed ID: 18034779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X, Ji Y, Chen J, Li S, Luo F.
    Nutrition; 2009 Apr 01; 25(4):373-8. PubMed ID: 19056239
    [Abstract] [Full Text] [Related]

  • 14. Increase in visfatin after weight loss induced by gastroplastic surgery.
    Krzyzanowska K, Mittermayer F, Krugluger W, Kopp HP, Schernthaner G.
    Obesity (Silver Spring); 2006 Nov 01; 14(11):1886-9. PubMed ID: 17135602
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated total and central adiposity and low physical activity are associated with insulin resistance in children.
    Krekoukia M, Nassis GP, Psarra G, Skenderi K, Chrousos GP, Sidossis LS.
    Metabolism; 2007 Feb 01; 56(2):206-13. PubMed ID: 17224334
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis.
    Martins C, Mazza do Nascimento M, Pecoits-Filho R, Leinig C, Gonçalves LF, Fuerbringer R, Stenvinkel P, Lindholm B, Riella MC.
    J Ren Nutr; 2007 Mar 01; 17(2):132-7. PubMed ID: 17321953
    [Abstract] [Full Text] [Related]

  • 18. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Romero E.
    Nutrition; 2008 Jun 01; 24(6):517-21. PubMed ID: 18343636
    [Abstract] [Full Text] [Related]

  • 19. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R, Akbay E, Muslu N, Sezer K, Cayan F.
    Gynecol Endocrinol; 2009 Apr 01; 25(4):241-5. PubMed ID: 19408173
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.